Sign in

Publications

Search in 13060 publications:

RSS
Time frame
13060 Publication(s)
Aug 24, 2023
Pseudohypoglykämie bei systemischer Sklerose
Broder S. Pseudohypoglykämie bei systemischer Sklerose - Irreführende Blutzuckerwerte. Swiss Medcial Forum 2023; 23:1254-1255.
Aug 24, 2023
Pseudohypoglykämie bei systemischer Sklerose
Aug 24, 2023

Swiss Medcial Forum 2023; 23:1254-1255

Broder Simon

more
Aug 23, 2023
Association of chocolate consumption with neurological and cardiovascular outcomes in atrial fibrillation: data from two Swiss atrial fibrillation cohort studies (Swiss-AF and BEAT-AF).
Stauber A, Mueller A, Rommers N, Aeschbacher S, Rodondi N, Bonati L, Beer J, Jeger R, Kurz D, Liedtke C, Ammann P, Di Valentino M, Chocano-Bedoya P, Kobza R, Kühne M, Conen D, Osswald S, Bernheim A. Association of chocolate consumption with neurological and cardiovascular outcomes in atrial fibrillation: data from two Swiss atrial fibrillation cohort studies (Swiss-AF and BEAT-AF). Swiss Med Wkly 2023; 153:40109.
Aug 23, 2023
Association of chocolate consumption with neurological and cardiovascular outcomes in atrial fibrillation: data from two Swiss atrial fibrillation cohort studies (Swiss-AF and BEAT-AF).
Aug 23, 2023

Swiss Med Wkly 2023; 153:40109

Stauber Annina, Mueller Andreas Marc, Rommers Nikki, Aeschbacher Stefanie, Rodondi Nicolas, Bonati Leo H, Beer Jürg Hans, Jeger Raban V, Kurz David J, Liedtke Claudia, Ammann Peter, Di Valentino Marcello, Chocano-Bedoya Patricia O, Kobza Richard, Kühne Michael, Conen David, Osswald Stefan, Bernheim Alain M

more
Aug 22, 2023
Immune checkpoint inhibitor-induced neurotoxicity is not associated with seroprevalence of neurotropic infections.
Schmitt C, Hoefsmit E, Fangmeier T, Kramer N, Kabakci C, González-Navajas J, Versluis J, Compter A, Harrer T, Mijočević H, Schubert S, Hundsberger T, Menzies A, Scolyer R, Long G, French L, Blank C, Heinzerling L. Immune checkpoint inhibitor-induced neurotoxicity is not associated with seroprevalence of neurotropic infections. Cancer Immunol Immunother 2023
Aug 22, 2023
Immune checkpoint inhibitor-induced neurotoxicity is not associated with seroprevalence of neurotropic infections.
Aug 22, 2023

Cancer Immunol Immunother 2023

Schmitt Christina, Hoefsmit E P, Fangmeier T, Kramer N, Kabakci C, González-Navajas Jose M, Versluis Judith M, Compter Annette, Harrer T, Mijočević H, Schubert Steffen, Hundsberger Thomas, Menzies A M, Scolyer Richard A, Long Georgina V, French Lars Einar, Blank Christian U, Heinzerling Lucie M

more
Aug 21, 2023
Oncoplastic breast surgery for patients with breast cancer.
Dines L, Stellander A, Schmidt V, Rose M. Oncoplastic breast surgery for patients with breast cancer. Ugeskr Laeger 2023; 185
Aug 21, 2023
Oncoplastic breast surgery for patients with breast cancer.
Aug 21, 2023

Ugeskr Laeger 2023; 185

Dines Laura Marie, Stellander Anne Kristine Larsen, Schmidt Volker, Rose Michael

more
Aug 21, 2023
Extended Adjuvant Endocrine Therapy in Early Breast Cancer Patients-Review and Perspectives.
Bekes I, Huober J. Extended Adjuvant Endocrine Therapy in Early Breast Cancer Patients-Review and Perspectives. Cancers (Basel) 2023; 15
Aug 21, 2023
Extended Adjuvant Endocrine Therapy in Early Breast Cancer Patients-Review and Perspectives.
Aug 21, 2023

Cancers (Basel) 2023; 15

Bekes Inga, Huober Jens

more
Aug 18, 2023
Genetic alterations and MRD refine risk assessment within KMT2A-rearranged B-cell precursor ALL in adult: a GRAALL study.
Kim R, Bergugnat H, Pastoret C, Pasquier F, Raffoux E, Larcher L, Passet M, Grardel N, Delabesse E, Kubetzko S, Caye-Eude A, Meyer C, Marschalek R, Lafage-Pochitaloff M, Thiebaut-Bertrand A, Balsat M, Escoffre-Barbe M, Blum S, Baumann M, Banos A, Straetmans N, Gallego-Hernanz M, Chalandon Y, Graux C, Soulier J, Leguay T, Hunault-Berger M, Huguet F, Lhéritier V, Dombret H, Boissel N, Clappier E. Genetic alterations and MRD refine risk assessment within KMT2A-rearranged B-cell precursor ALL in adult: a GRAALL study. Blood 2023
Aug 18, 2023
Genetic alterations and MRD refine risk assessment within KMT2A-rearranged B-cell precursor ALL in adult: a GRAALL study.
Aug 18, 2023

Blood 2023

Kim Rathana, Bergugnat Hugo, Pastoret Cedric, Pasquier Florence, Raffoux Emmanuel, Larcher Lise, Passet Marie, Grardel Nathalie, Delabesse Eric, Kubetzko Susanne, Caye-Eude Aurélie, Meyer Claus, Marschalek Rolf, Lafage-Pochitaloff Marina, Thiebaut-Bertrand Anne, Balsat Marie, Escoffre-Barbe Martine, Blum Sabine, Baumann Michael, Banos Anne, Straetmans Nicole, Gallego-Hernanz Maria-Pilar, Chalandon Yves, Graux Carlos, Soulier Jean, Leguay Thibaut, Hunault-Berger Mathilde, Huguet Françoise, Lhéritier Véronique, Dombret Hervé, Boissel Nicolas, Clappier Emmanuelle

more
Aug 17, 2023
The phenotypic presentation of adult individuals with SCL6A1-related neurodevelopmental disorders.
Johannesen K, Nielsen J, Sabers A, Isidor B, Kattentidt-Mouravieva A, Zieglgänsberger D, Heidlebaugh A, Oetjens K, Vidal A, Christensen J, Tiller J, Freed A, Møller R, Rubboli G. The phenotypic presentation of adult individuals with SCL6A1-related neurodevelopmental disorders. Front Neurosci 2023; 17:1216653.
Aug 17, 2023
The phenotypic presentation of adult individuals with SCL6A1-related neurodevelopmental disorders.
Aug 17, 2023

Front Neurosci 2023; 17:1216653

Johannesen Katrine M, Nielsen Jimmi, Sabers Anne, Isidor Bertrand, Kattentidt-Mouravieva Anja A, Zieglgänsberger Dominik, Heidlebaugh Alexis R, Oetjens Kathryn F, Vidal Anna Abuli, Christensen Jakob, Tiller Jacob, Freed Amber N, Møller Rikke S, Rubboli Guido

more
Aug 17, 2023
Perioperative Chemoimmunotherapy With Durvalumab for Muscle-Invasive Urothelial Carcinoma: Primary Analysis of the Single-Arm Phase II Trial SAKK 06/17.
Cathomas R, Rothschild S, Hayoz S, Bubendorf L, Özdemir B, Kiss B, Erdmann A, Aeppli S, Mach N, Strebel R, Hadaschik B, Berthold D, John H, Zihler D, Schmid M, Alborelli I, Schneider M, Musilova J, Spahn M, Petrausch U. Perioperative Chemoimmunotherapy With Durvalumab for Muscle-Invasive Urothelial Carcinoma: Primary Analysis of the Single-Arm Phase II Trial SAKK 06/17. J Clin Oncol 2023; 41:5131-5139.
Aug 17, 2023
Perioperative Chemoimmunotherapy With Durvalumab for Muscle-Invasive Urothelial Carcinoma: Primary Analysis of the Single-Arm Phase II Trial SAKK 06/17.
Aug 17, 2023

J Clin Oncol 2023; 41:5131-5139

Cathomas Richard, Rothschild Sacha I, Hayoz Stefanie, Bubendorf Lukas, Özdemir Berna C, Kiss Bernhard, Erdmann Andreas, Aeppli Stefanie, Mach Nicolas, Strebel Räto T, Hadaschik Boris, Berthold Dominik R, John Hubert, Zihler Deborah, Schmid Mathias, Alborelli Ilaria, Schneider Martina, Musilova Jana, Spahn Martin, Petrausch Ulf

more
Aug 17, 2023
Sex-Specific Implant Fixation Can Reduce Revision Rates in Total Hip Arthroplasty: Evidence From the Swiss National Joint Registry.
Ladurner A, Zdravkovic V, Giesinger K. Sex-Specific Implant Fixation Can Reduce Revision Rates in Total Hip Arthroplasty: Evidence From the Swiss National Joint Registry. J Arthroplasty 2023; 39:421-426.
Aug 17, 2023
Sex-Specific Implant Fixation Can Reduce Revision Rates in Total Hip Arthroplasty: Evidence From the Swiss National Joint Registry.
Aug 17, 2023

J Arthroplasty 2023; 39:421-426

Ladurner Andreas, Zdravkovic Vilijam, Giesinger Karlmeinrad

more
Aug 17, 2023
Pro-Con Debate: Should All General Anesthesia Be Done Using Target-Controlled Propofol Infusion Guided by Objective Monitoring of Depth of Anesthesia?
Schnider T, Nieuwenhuijs-Moeke G, Beck-Schimmer B, Hemmerling T. Pro-Con Debate: Should All General Anesthesia Be Done Using Target-Controlled Propofol Infusion Guided by Objective Monitoring of Depth of Anesthesia?. Anesth Analg 2023; 137:565-575.
Aug 17, 2023
Pro-Con Debate: Should All General Anesthesia Be Done Using Target-Controlled Propofol Infusion Guided by Objective Monitoring of Depth of Anesthesia?
Aug 17, 2023

Anesth Analg 2023; 137:565-575

Schnider Thomas, Nieuwenhuijs-Moeke Gertrude J, Beck-Schimmer Beatrice, Hemmerling Thomas M

more
Aug 16, 2023
Immunogenicity of High-Dose vs. MF59-adjuvanted vs. Standard Influenza Vaccine in Solid Organ Transplant Recipients: The STOP-FLU trial.
Mombelli M, Neofytos D, Huynh-Do U, Sánchez-Céspedes J, Stampf S, Golshayan D, Dahdal S, Stirnimann G, Schnyder A, Garzoni C, Venzin R, Magenta L, Schönenberger M, Walti L, Hirzel C, Munting A, Dickenmann M, Koller M, Aubert J, Steiger J, Pascual M, Müller T, Schuurmans M, Berger C, Binet F, Villard J, Müller N, Egli A, Cordero E, Van Delden C, Manuel O, Swiss Transplant Cohort Study. Immunogenicity of High-Dose vs. MF59-adjuvanted vs. Standard Influenza Vaccine in Solid Organ Transplant Recipients: The STOP-FLU trial. Clin Infect Dis 2023
Aug 16, 2023
Immunogenicity of High-Dose vs. MF59-adjuvanted vs. Standard Influenza Vaccine in Solid Organ Transplant Recipients: The STOP-FLU trial.
Aug 16, 2023

Clin Infect Dis 2023

Mombelli Matteo, Neofytos Dionysios, Huynh-Do Uyen, Sánchez-Céspedes Javier, Stampf Susanne, Golshayan Délaviz, Dahdal Suzan, Stirnimann Guido, Schnyder Aurelia, Garzoni Christian, Venzin Reto M, Magenta Lorenzo, Schönenberger Melanie, Walti Laura N, Hirzel Cédric, Munting Aline, Dickenmann Michael, Koller Michael, Aubert John-David, Steiger Jürg, Pascual Manuel, Müller Thomas F, Schuurmans Macé M, Berger Christoph T, Binet Françoise-Isabelle, Villard Jean, Müller Nicolas J., Egli Adrian, Cordero Elisa, Van Delden Christian, Manuel Oriol, Swiss Transplant Cohort Study

more
Aug 16, 2023
Quality criteria for pediatric oncology centers: A systematic literature review.
Schladerer S, Otth M, Scheinemann K. Quality criteria for pediatric oncology centers: A systematic literature review. Cancer Med 2023; 12:18999-19012.
Aug 16, 2023
Quality criteria for pediatric oncology centers: A systematic literature review.
Aug 16, 2023

Cancer Med 2023; 12:18999-19012

Schladerer Sarah P, Otth Maria, Scheinemann Katrin

more
Aug 16, 2023
The Effects of Hospitalisation on the Serum Metabolome in COVID-19 Patients.
Hensen T, Fässler D, O'Mahony L, Albrich W, Barda B, Garzoni C, Kleger G, Pietsch U, Suh N, Hertel J, Thiele I. The Effects of Hospitalisation on the Serum Metabolome in COVID-19 Patients. Metabolites 2023; 13
Aug 16, 2023
The Effects of Hospitalisation on the Serum Metabolome in COVID-19 Patients.
Aug 16, 2023

Metabolites 2023; 13

Hensen Tim, Fässler Daniel, O'Mahony Liam, Albrich Werner, Barda Beatrice, Garzoni Christian, Kleger Gian-Reto, Pietsch Urs, Suh Noémie, Hertel Johannes, Thiele Ines

more
Aug 15, 2023
Interdisciplinary Swiss consensus recommendations on staging and treatment of advanced prostate cancer.
Templeton A, Omlin A, Berthold D, Beyer J, Burger I, Eberli D, Engeler D, Fankhauser C, Fischer S, Gillessen S, Nicolas G, Kroeze S, Lorch A, Müntener M, Papachristofilou A, Schäfer N, Seiler D, Stenner-Liewen F, Tsantoulis P, Vlajnic T, Zilli T, Zwahlen D, Cathomas R. Interdisciplinary Swiss consensus recommendations on staging and treatment of advanced prostate cancer. Swiss Med Wkly 2023; 153:40108.
Aug 15, 2023
Interdisciplinary Swiss consensus recommendations on staging and treatment of advanced prostate cancer.
Aug 15, 2023

Swiss Med Wkly 2023; 153:40108

Templeton Arnoud J, Omlin Aurelius, Berthold Dominik R, Beyer Jörg, Burger Irene A, Eberli Daniel, Engeler Daniel, Fankhauser Christian Daniel, Fischer Stefanie, Gillessen Silke, Nicolas Guillaume, Kroeze Stephanie G C, Lorch Anja, Müntener Michael, Papachristofilou Alexandros, Schäfer Niklaus G, Seiler Daniel, Stenner-Liewen Frank, Tsantoulis Petros, Vlajnic Tatjana, Zilli Thomas, Zwahlen Daniel Rudolf, Cathomas Richard

more
Aug 14, 2023
Blunt rupture of the biceps brachii muscle - The "parachute injury" in a wake surfer - A case report.
Kramer M, Manser M, Kim O, Jost B, Spross C. Blunt rupture of the biceps brachii muscle - The "parachute injury" in a wake surfer - A case report. Trauma Case Rep 2023; 47:100906.
Aug 14, 2023
Blunt rupture of the biceps brachii muscle - The "parachute injury" in a wake surfer - A case report.
Aug 14, 2023

Trauma Case Rep 2023; 47:100906

Kramer Manuel, Manser Melanie, Kim Olaf Chan-Hi, Jost Bernhard, Spross Christian

more
Aug 12, 2023
STAR SIGN study: Evaluation of COVID-19 vaccine efficacy against the SARS-CoV-2 variants BQ.1.1 and XBB.1.5 in patients with inflammatory bowel disease.
Woelfel S, Dütschler J, König M, Dulovic A, Graf N, Junker D, Oikonomou V, Krieger-Grübel C, Truniger S, Franke A, Eckhold A, Forsch K, Koller S, Wyss J, Krupka N, Oberholzer M, Frei N, Geissler N, Schaub P, STAR SIGN Study Investigators, Albrich W, Friedrich M, Schneiderhan-Marra N, Misselwitz B, Korte W, Bürgi J, Brand S. STAR SIGN study: Evaluation of COVID-19 vaccine efficacy against the SARS-CoV-2 variants BQ.1.1 and XBB.1.5 in patients with inflammatory bowel disease. Aliment Pharmacol Ther 2023; 58:678-691.
Aug 12, 2023
STAR SIGN study: Evaluation of COVID-19 vaccine efficacy against the SARS-CoV-2 variants BQ.1.1 and XBB.1.5 in patients with inflammatory bowel disease.
Aug 12, 2023

Aliment Pharmacol Ther 2023; 58:678-691

Woelfel Simon, Dütschler Joel, König Marius, Dulovic Alex, Graf Nicole, Junker Daniel, Oikonomou Vasileios, Krieger-Grübel Claudia, Truniger Samuel, Franke Annett, Eckhold Annika, Forsch Kristina, Koller Seraina, Wyss Jacqueline, Krupka Niklas, Oberholzer Melanie, Frei Nicola Fabian, Geissler Nora, Schaub Peter, STAR SIGN Study Investigators, Albrich Werner, Friedrich Matthias, Schneiderhan-Marra Nicole, Misselwitz Benjamin, Korte Wolfgang C, Bürgi Justus J, Brand Stephan

more
Aug 11, 2023
Relevance of National Institutes of Health Stroke Scale subitems for best revascularization therapy in minor stroke patients with large vessel occlusion: An observational multicentric study.
Palazzo P, Padlina G, Dobrocky T, Strambo D, Seners P, Mechtouff L, Turc G, Rosso C, Almiri W, Antonenko K, Laksiri N, Sibon I, Detante O, Mordasini P, Michel P, Heldner M, MINOR STROKE Collaborators. Relevance of National Institutes of Health Stroke Scale subitems for best revascularization therapy in minor stroke patients with large vessel occlusion: An observational multicentric study. Eur J Neurol 2023; 30:3741-3750.
Aug 11, 2023
Relevance of National Institutes of Health Stroke Scale subitems for best revascularization therapy in minor stroke patients with large vessel occlusion: An observational multicentric study.
Aug 11, 2023

Eur J Neurol 2023; 30:3741-3750

Palazzo Paola, Padlina Giovanna, Dobrocky Tomas, Strambo Davide, Seners Pierre, Mechtouff Laura, Turc Guillaume, Rosso Charlotte, Almiri William, Antonenko Kateryna, Laksiri Nadia, Sibon Igor, Detante Olivier, Mordasini Pasquale, Michel Patrik, Heldner Mirjam R, MINOR STROKE Collaborators

more
Aug 10, 2023
Lysin (K)-specific demethylase 1 inhibition enhances proteasome inhibitor response and overcomes drug resistance in multiple myeloma.
Bandini C, Mereu E, Paradzik T, Labrador M, Maccagno M, Cumerlato M, Oreglia F, Prever L, Manicardi V, Taiana E, Ronchetti D, D'Agostino M, Gay F, Larocca A, Besse L, Merlo G, Hirsch E, Ciarrocchi A, Inghirami G, Neri A, Piva R. Lysin (K)-specific demethylase 1 inhibition enhances proteasome inhibitor response and overcomes drug resistance in multiple myeloma. Exp Hematol Oncol 2023; 12:71.
Aug 10, 2023
Lysin (K)-specific demethylase 1 inhibition enhances proteasome inhibitor response and overcomes drug resistance in multiple myeloma.
Aug 10, 2023

Exp Hematol Oncol 2023; 12:71

Bandini Cecilia, Mereu Elisabetta, Paradzik Tina, Labrador Maria, Maccagno Monica, Cumerlato Michela, Oreglia Federico, Prever Lorenzo, Manicardi Veronica, Taiana Elisa, Ronchetti Domenica, D'Agostino Mattia, Gay Francesca, Larocca Alessandra, Besse Lenka, Merlo Giorgio Roberto, Hirsch Emilio, Ciarrocchi Alessia, Inghirami Giorgio Ga, Neri Antonino, Piva Roberto

more
Aug 10, 2023
Pertuzumab Plus Trastuzumab With or Without Chemotherapy Followed by Emtansine in ERBB2-Positive Metastatic Breast Cancer: A Secondary Analysis of a Randomized Clinical Trial.
Huober J, Weder P, Ribi K, Thürlimann B, Thery J, Li Q, Vanlemmens L, Guiu S, Brain E, Grenier J, Dalenc F, Levy C, Savoye A, Müller A, Membrez-Antonioli V, Gerard M, Lemonnier J, Hawle H, Dietrich D, Boven E, Bonnefoi H, Swiss Group for Clinical Cancer Research, Unicancer Breast Group, and Dutch Breast Cancer Research Group. Pertuzumab Plus Trastuzumab With or Without Chemotherapy Followed by Emtansine in ERBB2-Positive Metastatic Breast Cancer: A Secondary Analysis of a Randomized Clinical Trial. JAMA Oncol 2023
Aug 10, 2023
Pertuzumab Plus Trastuzumab With or Without Chemotherapy Followed by Emtansine in ERBB2-Positive Metastatic Breast Cancer: A Secondary Analysis of a Randomized Clinical Trial.
Aug 10, 2023

JAMA Oncol 2023

Huober Jens, Weder Patrik, Ribi Karin, Thürlimann Beat, Thery Jean-Christophe, Li Qiyu, Vanlemmens Laurence, Guiu Séverine, Brain Etienne, Grenier Julien, Dalenc Florence, Levy Christelle, Savoye Aude-Marie, Müller Andreas S, Membrez-Antonioli Véronique, Gerard Marie-Aline, Lemonnier Jérôme, Hawle Hanne, Dietrich Daniel, Boven Epie, Bonnefoi Hervé R, Swiss Group for Clinical Cancer Research, Unicancer Breast Group, and Dutch Breast Cancer Research Group

more
Aug 7, 2023
Autoimmunity in immune checkpoint inhibitor-induced immune-related adverse events: A focus on autoimmune skin toxicity and pneumonitis.
Berner F, Flatz L. Autoimmunity in immune checkpoint inhibitor-induced immune-related adverse events: A focus on autoimmune skin toxicity and pneumonitis. Immunol Rev 2023; 318:37-50.
Aug 7, 2023
Autoimmunity in immune checkpoint inhibitor-induced immune-related adverse events: A focus on autoimmune skin toxicity and pneumonitis.
Aug 7, 2023

Immunol Rev 2023; 318:37-50

Berner Fiamma, Flatz Lukas

more

We use cookies and tracking technologies according to our privacy policy to provide you with the best possible web experience. To the privacy policy